GDE7 produces cyclic phosphatidic acid in the ER lumen functioning as a lysophospholipid mediator

[1]  R. Kannagi,et al.  Hypoxia increases cellular levels of phosphatidic acid and lysophospholipids in undifferentiated Caco-2 cells. , 2023, Lipids.

[2]  Tong Zhu,et al.  Development and validation of a simple and rapid HILIC-MS/MS method for the quantification of low-abundant lysoglycerophospholipids in human plasma , 2022, Analytical and Bioanalytical Chemistry.

[3]  T. Hla,et al.  Lysophospholipid Mediators in Health and Disease. , 2021, Annual review of pathology.

[4]  K. Tsuboi,et al.  Development of a selective fluorescence-based enzyme assay for glycerophosphodiesterase family members GDE4 and GDE7 , 2021, Journal of lipid research.

[5]  Takashi Sato,et al.  Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro. , 2021, Microvascular research.

[6]  K. Tsuboi,et al.  Sphingosine 1-phosphate receptor type 2 positively regulates interleukin (IL)-4/IL-13-induced STAT6 phosphorylation. , 2021, Cellular signalling.

[7]  K. Tsuboi,et al.  ATF4-mediated transcriptional regulation protects against β-cell loss during endoplasmic reticulum stress in a mouse model , 2021, Molecular metabolism.

[8]  N. Yanaka,et al.  Characterization of recombinant murine GDE4 and GDE7, enzymes producing lysophosphatidic acid and/or cyclic phosphatidic acid. , 2021, Journal of biochemistry.

[9]  T. Hirokawa,et al.  2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition , 2021, Scientific Reports.

[10]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[11]  Felicia Gilels,et al.  Primed to die: an investigation of the genetic mechanisms underlying noise-induced hearing loss and cochlear damage in homozygous Foxo3-knockout mice , 2021, Cell Death & Disease.

[12]  M. Gotoh,et al.  Adenine nucleotide translocase 2, a putative target protein for 2-carba cyclic phosphatidic acid in microglial cells. , 2021, Cellular signalling.

[13]  F. Lima,et al.  Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies , 2021, Signal Transduction and Targeted Therapy.

[14]  M. Frohman,et al.  Structure and regulation of human phospholipase D. , 2021, Advances in biological regulation.

[15]  Long N Nguyen,et al.  Emerging roles of lysophospholipids in health and disease. , 2020, Progress in lipid research.

[16]  A. Ooshima,et al.  The lysophospholipase D enzyme Gdpd3 is required to maintain chronic myelogenous leukaemia stem cells , 2020, Nature Communications.

[17]  Giuseppina Augimeri,et al.  The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies , 2020, Cancers.

[18]  K. Tsuboi,et al.  Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts. , 2020, Experimental cell research.

[19]  Xiang Chen,et al.  The mechanisms of lysophosphatidylcholine in the development of diseases. , 2020, Life sciences.

[20]  K. Szigeti,et al.  Copy Number Variations in Adult-onset Neuropsychiatric Diseases , 2018, Current genomics.

[21]  N. Yamazaki,et al.  Calcium-dependent generation of N-acylethanolamines and lysophosphatidic acids by glycerophosphodiesterase GDE7. , 2016, Biochimica et biophysica acta.

[22]  M. Gotoh,et al.  The effect of cyclic phosphatidic acid on the proliferation and differentiation of mouse cerebellar granule precursor cells during cerebellar development , 2015, Brain Research.

[23]  T. Uyama,et al.  Glycerophosphodiesterase GDE4 as a novel lysophospholipase D: a possible involvement in bioactive N-acylethanolamine biosynthesis. , 2015, Biochimica et biophysica acta.

[24]  H. Haniu,et al.  Heart-type fatty-acid-binding protein (FABP3) is a lysophosphatidic acid-binding protein in human coronary artery endothelial cells , 2014, FEBS open bio.

[25]  M. Gotoh,et al.  Cyclic phosphatidic acid and lysophosphatidic acid induce hyaluronic acid synthesis via CREB transcription factor regulation in human skin fibroblasts. , 2014, Biochimica et biophysica acta.

[26]  Shuli Wang,et al.  Lysophosphatidic Acid Activates Peroxisome Proliferator Activated Receptor-γ in CHO Cells That Over-Express Glycerol 3-Phosphate Acyltransferase-1 , 2011, PloS one.

[27]  T. Tsukahara,et al.  Cyclic phosphatidic acid decreases proliferation and survival of colon cancer cells by inhibiting peroxisome proliferator‐activated receptor γ , 2010, Prostaglandins & other lipid mediators.

[28]  Chunxiang Zhang,et al.  Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPARgamma by cyclic phosphatidic acid. , 2010, Molecular cell.

[29]  L. Carbone,et al.  Elevated Serum Levels of Arachidonoyl-lysophosphatidic Acid and Sphingosine 1-Phosphate in Systemic Sclerosis , 2009, International journal of medical sciences.

[30]  Sarah A. Scott,et al.  Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity. , 2009, Bioorganic & medicinal chemistry letters.

[31]  M. Gelb,et al.  5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a Phospholipase D Pharmacological Inhibitor That Alters Cell Spreading and Inhibits Chemotaxis , 2009, Molecular Pharmacology.

[32]  N. Samadi,et al.  Autotaxin protects MCF-7 breast cancer and MDA-MB-435 melanoma cells against Taxol-induced apoptosis , 2009, Oncogene.

[33]  G. Ferry,et al.  S32826, A Nanomolar Inhibitor of Autotaxin: Discovery, Synthesis and Applications as a Pharmacological Tool , 2008, Journal of Pharmacology and Experimental Therapeutics.

[34]  Y. Fujiwara.  Cyclic phosphatidic acid - a unique bioactive phospholipid. , 2008, Biochimica et biophysica acta.

[35]  Alfonso Valencia,et al.  firestar—prediction of functionally important residues using structural templates and alignment reliability , 2007, Nucleic Acids Res..

[36]  G. Prestwich,et al.  α‐Substituted Phosphonate Analogues of Lysophosphatidic Acid (LPA) Selectively Inhibit Production and Action of LPA , 2007, ChemMedChem.

[37]  T. Hatanaka,et al.  C‐terminal loop of Streptomyces phospholipase D has multiple functional roles , 2006, Protein science : a publication of the Protein Society.

[38]  S. Payne,et al.  A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells , 2005, The Journal of cell biology.

[39]  A. Tokumura.  Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators , 2004, Journal of cellular biochemistry.

[40]  D. Corda,et al.  GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. C. Hinshaw,et al.  Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARγ agonist , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Juretic,et al.  Basic Charge Clusters and Predictions of Membrane Protein Topology , 2002, J. Chem. Inf. Comput. Sci..

[43]  István Simon,et al.  The HMMTOP transmembrane topology prediction server , 2001, Bioinform..

[44]  A. Krogh,et al.  Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.

[45]  W. Boyar,et al.  Characterization of human PLD2 and the analysis of PLD isoform splice variants , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  J. Lehmann,et al.  A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation , 1995, Cell.

[47]  B. Spiegelman,et al.  15-Deoxy-Δ 12,14-Prostaglandin J 2 is a ligand for the adipocyte determination factor PPARγ , 1995, Cell.

[48]  D. Wilton,et al.  The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. , 1994, The Biochemical journal.

[49]  M S Waterman,et al.  Identification of common molecular subsequences. , 1981, Journal of molecular biology.

[50]  G. Gores,et al.  Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis. , 2012, American journal of physiology. Gastrointestinal and liver physiology.